Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12595298 | Anti-NGF antibody and antigen-binding fragment thereof, preparation method, and application thereof | 🖼🧊📄§ | 2026-04-07 | 2041-08-02 | 0 | 31 |
| 12594263 | CBL inhibitors and compositions for expansion of immune cells | 🖼🧊📄§ | 2026-04-07 | 2040-09-23 | 0 | 31 |
| 12594297 | Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury | 🖼🧊📄§ | 2026-04-07 | 2040-08-03 | 0 | 31 |
| 12594281 | Pharmaceutical dosage forms and methods of use | 🖼🧊📄§ | 2026-04-07 | 2045-05-16 | 0 | 31 |
| 12594252 | Methods for treating inflammatory skin conditions | 🖼🧊📄§ | 2026-04-07 | 2042-06-20 | 0 | 31 |
| 12595310 | Compositions and methods for transferrin receptor 1 targeting | 🖼🧊📄§ | 2026-04-07 | 2040-11-06 | 0 | 31 |
| 12594279 | Composition for preventing or treating TNF-α-related disease, comprising hydroflumethiazide as active ingredient | 🖼🧊📄§ | 2026-04-07 | 2041-11-05 | 0 | 31 |
| 12594274 | Method for preparing a crystalline form of rabeximod | 🖼🧊📄§ | 2026-04-07 | 2041-06-10 | 0 | 31 |
| 12594266 | Triterpenoid antifungals for the treatment or prevention of Pneumocystis spp. pneumonia | 🖼🧊📄§ | 2026-04-07 | 2040-02-25 | 0 | 31 |
| 12594258 | Inhibitors of MHC-I Nef downmodulation for treating HIV | 🖼🧊📄§ | 2026-04-07 | 2040-12-16 | 0 | 31 |
| 12594303 | Composition comprising exosomes derived from induced pluripotent stem cell-derived mesenchymal stem cell progenitor for prevention or treatment of non-alcoholic steatohepatitis | 🖼🧊📄§ | 2026-04-07 | 2040-08-12 | 0 | 31 |
| 12594282 | Use of small molecule compounds in the treatment of diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury | 🖼🧊📄§ | 2026-04-07 | 2041-02-26 | 0 | 31 |
| 12594257 | Means and methods for improving anti-tumoral efficacy of transmembrane channel protein blockers | 🖼🧊📄§ | 2026-04-07 | 2042-06-02 | 0 | 31 |
| 12594323 | Methods of reducing neuroinflammation | 🖼🧊📄§ | 2026-04-07 | 2043-04-13 | 0 | 31 |
| 12596122 | LILRB2 antibodies and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-01-28 | 0 | 31 |
| 12594278 | Method for treatment of muscular dystrophy | 🖼🧊📄§ | 2026-04-07 | 2040-07-16 | 0 | 31 |
| 12595302 | CLDN18.2 binding molecule | 🖼🧊📄§ | 2026-04-07 | 2040-05-21 | 0 | 31 |
| 12595307 | Anti-CTLA4 monoclonal antibodies and chimeric antigen receptors | 🖼🧊📄§ | 2026-04-07 | 2041-06-09 | 0 | 31 |
| 12595246 | Crystalline and amorphous forms of N-(5-((4-ethylpiperazin-1-yl)methyl)pyridine-2-yl)-5-fluoro-4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-amine and its salts, and preparation methods and therapeutic uses thereof | 🖼🧊📄§ | 2026-04-07 | 2040-03-20 | 0 | 31 |
| 12595306 | TREM2 stabilizing antibodies | 🖼🧊📄§ | 2026-04-07 | 2044-12-23 | 0 | 31 |
| 12595232 | DRG-MDM2-1 for use as a novel Mouse Double Minute 2 (MDM2) inhibitor | 🖼🧊📄§ | 2026-04-07 | 2041-02-16 | 0 | 31 |
| 12595304 | Antibodies specific to glycosylated LAG3 and methods of use thereof | 🖼🧊📄§ | 2026-04-07 | 2040-10-09 | 0 | 31 |
| 12594317 | Traditional Chinese medicine composition for treating novel coronavirus pneumonia, preparation method, detection method, and use thereof | 🖼🧊📄§ | 2026-04-07 | 2040-11-13 | 0 | 31 |
| 12594261 | Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases | 🖼🧊📄§ | 2026-04-07 | 2039-12-14 | 0 | 31 |
| 12595517 | Method to treat and stratify a patient suffering from a cancer | 🖼🧊📄§ | 2026-04-07 | 2041-09-13 | 0 | 31 |
| 12595312 | CD133-binding agents and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-10-26 | 0 | 31 |
| 12595290 | T cell receptors specific for mesothelin and their use in immunotherapy | 🖼🧊📄§ | 2026-04-07 | 2039-11-08 | 0 | 31 |
| 12594290 | IP and IP analogs dosage regimens for the treatment of ectopic calcifications | 🖼🧊📄§ | 2026-04-07 | 2045-02-27 | 0 | 31 |
| 12594291 | Intratumoral alpha-emitter radiation and activation of cytoplasmatic sensors for intracellular pathogen | 🖼🧊📄§ | 2026-04-07 | 2039-10-31 | 0 | 31 |
| 12594324 | Methods and compositions for treatment of pancreatic cancer | 🖼🧊📄§ | 2026-04-07 | 2040-06-30 | 0 | 31 |
| 12594285 | Compositions and methods for protecting against airborne pathogens and irritants | 🖼🧊📄§ | 2026-04-07 | 2041-10-08 | 0 | 31 |
| 12595285 | LMP-1 expressing cells and methods of use thereof | 🖼🧊📄§ | 2026-04-07 | 2042-05-13 | 0 | 31 |
| 12594283 | Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug | 🖼🧊📄§ | 2026-04-07 | 2040-10-26 | 0 | 31 |
| 12594287 | Human milk oligosaccharide for improving health of intestinal microenvironment and use thereof | 🖼🧊📄§ | 2026-04-07 | 2041-01-27 | 0 | 31 |
| 12594308 | Methods of preparing a postbiotic composition | 🖼🧊📄§ | 2026-04-07 | 2044-10-08 | 0 | 31 |
| 12595481 | Methods and compositions for neuroprotection | 🖼🧊📄§ | 2026-04-07 | 2040-11-25 | 0 | 31 |
| 12594309 | Bifidobacteria for treating diabetes and related conditions | 🖼🧊📄§ | 2026-04-07 | 2043-12-06 | 0 | 31 |
| 12595289 | Therapeutic agent for breast cancer comprising BIG3-PHB2 interaction-inhibiting peptide derived from PHB2 | 🖼🧊📄§ | 2026-04-07 | 2039-11-28 | 0 | 31 |
| 12594280 | Antiviral compositions for treating the flu | 🖼🧊📄§ | 2026-04-07 | 2042-05-31 | 0 | 31 |
| 12595250 | Substituted pyrimidine compounds as multifunctional radical quenchers and their uses | 🖼🧊📄§ | 2026-04-07 | 2042-06-15 | 0 | 31 |
| 12594268 | Methods of treating Fabry disease in patients having a mutation in the GLA gene | 🖼🧊📄§ | 2026-04-07 | 2039-01-16 | 0 | 31 |
| 12594316 | Plant composition, traditional Chinese medicine composition and use thereof | 🖼🧊📄§ | 2026-04-07 | 2042-10-19 | 0 | 31 |
| 12594267 | Capsid inhibitors for the treatment of HIV | 🖼🧊📄§ | 2026-04-07 | 2044-02-27 | 0 | 31 |
| 12595309 | Compositions and methods for treatment of thyroid eye disease | 🖼🧊📄§ | 2026-04-07 | 2044-11-08 | 0 | 31 |
| 12594244 | Therapeutic compositions for treatment of human immunodeficiency virus | 🖼🧊📄§ | 2026-04-07 | 2045-09-29 | 0 | 31 |
| 12594343 | Treatment of cancer | 🖼🧊📄§ | 2026-04-07 | 2041-01-28 | 0 | 31 |
| 12595236 | Pyrimidine-2,4-diamine compound and preparation method and application thereof | 🖼🧊📄§ | 2026-04-07 | 2042-01-21 | 0 | 31 |
| 12594191 | Hemostatic textile | 🖼🧊📄§ | 2026-04-07 | 2042-03-31 | 0 | 31 |
| 12594288 | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection | 🖼🧊📄§ | 2026-04-07 | 2043-06-05 | 0 | 31 |
| 12595469 | Treatment of retinitis pigmentosa using improved engineered meganucleases | 🖼🧊📄§ | 2026-04-07 | 2041-05-11 | 0 | 31 |